Skip to main content
Top
Published in: Journal of Public Health 5/2017

01-10-2017 | Review Article

Tobacco smoking and multiple sclerosis: a systematic review of systematic and narrative reviews of observational studies

Authors: Insa Backhaus, Alice Mannocci, Giuseppe La Torre

Published in: Journal of Public Health | Issue 5/2017

Login to get access

Abstract

Aim

The aim of this review was to systematically review systematic and narrative reviews of observational studies published on the relation between tobacco smoking and multiple sclerosis (MS).

Subjects and methods

A systematic search of the literature in PubMed and Scopus was conducted in June 2016. Two authors independently reviewed the search results and extracted key points. Review studies (i.e., review, systematic, narrative, or meta-analysis) that reported on smoking and MS were selected. The methodological quality of included systematic reviews and meta-analyses was assessed using the AMSTAR checklist. The methodological quality of narrative reviews was evaluated using a seven-item measure developed by the authors.

Results

Seventeen reviews met the inclusion criteria and were categorized as either systematic reviews or narrative reviews. Smoking was associated with increased risk of MS for ever- compared with never-smokers and current compared with non-smokers. The summary odds ratio of MS for ever-smokers versus never-smokers varied between 1.40 (95% CI: 1.29–1.52) and 1.46 (95% CI: 1.33–1.59).

Conclusion

This review of reviews identifies smoking as a risk factor for MS susceptibility. However, more research is needed to conclusively establish the mechanisms driving this association.
Appendix
Available only for authorised users
Literature
go back to reference Backhaus I, Mannocci A, Lemmens PHHM, La Torre G (2016) Smoking as a risk factor for developing multiple sclerosis: a meta-analysis of observational studies. Clin Ter 167:82–92PubMed Backhaus I, Mannocci A, Lemmens PHHM, La Torre G (2016) Smoking as a risk factor for developing multiple sclerosis: a meta-analysis of observational studies. Clin Ter 167:82–92PubMed
go back to reference Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2000) Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain J Neurol 123(Pt 9):1845–1849CrossRef Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2000) Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain J Neurol 123(Pt 9):1845–1849CrossRef
go back to reference Hedström AK, Sundqvist E, Bäärnhielm M, Nordin N, Hillert J, Kockum I, Olsson T, Alfredsson L (2011) Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain J Neurol 134:653–664. doi:10.1093/brain/awq371 CrossRef Hedström AK, Sundqvist E, Bäärnhielm M, Nordin N, Hillert J, Kockum I, Olsson T, Alfredsson L (2011) Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain J Neurol 134:653–664. doi:10.​1093/​brain/​awq371 CrossRef
go back to reference Jafari N (2012) Risk factors in cause and course of multiple sclerosis. Naghmeh Jafari Jafari N (2012) Risk factors in cause and course of multiple sclerosis. Naghmeh Jafari
go back to reference Jafari N, Hintzen RQ (2011) The association between cigarette smoking and multiple sclerosis. J Neurol Sci 311:78–85CrossRefPubMed Jafari N, Hintzen RQ (2011) The association between cigarette smoking and multiple sclerosis. J Neurol Sci 311:78–85CrossRefPubMed
go back to reference Levine S (1967) Experimental cyanide encephalopathy: gradients of susceptibility in the corpus callosum. J Neuropathol Exp Neurol 26:214–222CrossRefPubMed Levine S (1967) Experimental cyanide encephalopathy: gradients of susceptibility in the corpus callosum. J Neuropathol Exp Neurol 26:214–222CrossRefPubMed
go back to reference McGowan J, Sampson M (2005) Systematic reviews need systematic searchers. J med Libr Assoc JMLA 93:74–80PubMed McGowan J, Sampson M (2005) Systematic reviews need systematic searchers. J med Libr Assoc JMLA 93:74–80PubMed
go back to reference Simon KC, Van der Mei IAF, Munger KL, Ponsonby A, Dickinson J, Dwyer T, Sundström P, Ascherio A (2010) Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1* 1501 on multiple sclerosis risk.Neurology 74(17):1365–1371. doi:10.1212/WNL.0b013e3181dad57e Simon KC, Van der Mei IAF, Munger KL, Ponsonby A, Dickinson J, Dwyer T, Sundström P, Ascherio A (2010) Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1* 1501 on multiple sclerosis risk.Neurology 74(17):1365–1371. doi:10.​1212/​WNL.​0b013e3181dad57e​
go back to reference Tullman MJ (2013) Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care 19:S15–S20PubMed Tullman MJ (2013) Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care 19:S15–S20PubMed
go back to reference World Health Organization (2008) Atlas multiple sclerosis resources in the world 2008. Accessed 10 June 2016 World Health Organization (2008) Atlas multiple sclerosis resources in the world 2008. Accessed 10 June 2016
Metadata
Title
Tobacco smoking and multiple sclerosis: a systematic review of systematic and narrative reviews of observational studies
Authors
Insa Backhaus
Alice Mannocci
Giuseppe La Torre
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Public Health / Issue 5/2017
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI
https://doi.org/10.1007/s10389-017-0811-6

Other articles of this Issue 5/2017

Journal of Public Health 5/2017 Go to the issue